At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Completed

• Conditions: Cervical Cancer; Chronic Inflammatory Demyelinating Polyneuropathy; Endometriosis; Hepatitis B; Idiopathic Thrombocytopenic Purpura; Leukemia; Ovarian Cancer; Parkinson's Disease; Prostate Cancer; Skin Cancer

• Registration Number: NCT01931644
• Lead Sponsor: Sanguine Biosciences

Brief Summary

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Detailed Description

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Study Timeline

• Study Start: 2013-07
• Study First Submitted: 2013-08-23
• Study First Submitted QC: 2013-08-26
• Study First Posted: 2013-08-29
• Status Verified: 2024-04
• Primary Completion: 2024-04
• Study Completion: 2024-04
• Last Update Submitted: 2024-04-16
• Last Update Posted: 2024-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 17667

Inclusion Criteria

• All adults 18-100 years old
• Able to provide proof of diagnosis
• Live in USA

Exclusion Criteria

• Younger than 18 years old
• Receipt of blood products within 30 days of study blood collection
• Receipt of investigational drug within 30 days of study blood collection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biospecimen & Clinical Data Collection	10 years	To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results

Trial Locations

Locations (1)

Sanguine Biosciences; 🇺🇸 Los Angeles, California, United States